While adipose tissue is increasingly recognized as a legitimate immune organ in PCOS patients, in endometriosis patients, the disease itself contributes to the production of inflammatory effectors such as leptin, tumor necrosis factor-alpha and interleukin-6 with reduced production of adiponectin, potentially leading to insulin resistance. Here, ADIPOQ is linked to polycystic ovary syndrome.